Key opinion leaders (KOLs) are important to pharma, as they lend a qualified and esteemed voice to your brand strategy. While industry regulations provide substantial hurdles for pharma communications, KOLs have better engagement with larger physician networks. Traditionally, the value of KOLs was in their ability to move a market. Although this fact hasn’t changed, […]

Exciting new developments emerge from the oncology and hematology fields constantly. While many changes unfold over time, some announcements, new discoveries, and novel products are unveiled at annual conferences. Major oncology conferences include those of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Important hematology conferences include the […]

At Aptitude Health, we strive to understand patterns of care that affect cancer patients not enrolled in clinical trials. We identify factors influencing prescribing habits that shape best practices and essentially get to the why. CASES Summits are regional events where approximately 60 oncologists and hematologists from large community practices along with leading scientific experts […]

The fields of oncology and hematology are fast-paced. New studies are published every day, offering fresh information and insights into diseases and treatments. This emerging research changes the landscape of medical information on which clinicians base their decisions. In addition, doctors’ experiences and collaborations within clinics and hospitals evolve over time. This progression impacts how […]

Traditionally, pharma has engaged with stakeholders during physical meetings to seek input. In today’s environment, however, healthcare providers are less and less inclined to travel across the globe for a 1- or 2-day meeting. This puts pharma companies under pressure, as they continue to have a need for insights into treatment patterns, and filling meetings […]

At Aptitude Health, the daily project portfolio for the Medical Publications team is extremely diverse but boils down to one thing: Effectively communicating the clinical relevance of our clients’ products. Such communication requires well-researched content that is of high quality, accurate, and up to date with the newest medical developments. With all the available articles, […]

For pharma reps, there is a historic battle to gain access to targeted physicians. And with a growing number of patient appointments packed into each day, reps can expect even stiffer waiting room competition and tighter restrictions on physician access.

Along with numerous networking opportunities, the takeaways regarding industry trends, innovations, discoveries, and advancements are the major benefits of attending an oncology conference. But often, due to the grandiosity of such events, it’s difficult to walk away feeling like you’ve experienced everything you had planned.

Medical communications agencies generate reports on oncology insights derived from a variety of industry-sponsored activities. Often these activities are on 1 particular company or product, which leads to discussions focusing on 1 specific topic. But insights reports can also range in scope and provide a look at the current oncology landscape from a broader perspective. […]